Post

Turn Bio and HanAll to develop therapies for age-related conditions

Turn Biotechnologies (Turn Bio) has entered an exclusive worldwide licensing agreement with HanAll Biopharma to develop therapies for age-related eye …

Gilead and Cartography enter deal to develop cancer therapies

Cartography Biosciences has announced a strategic partnership with Gilead Sciences, focusing on the discovery and development of therapies against new …

Merck introduces sterility testing solution for pharma quality control

Merck KGaA, based in Darmstadt, Germany, has introduced the M-Trace Software & Mobile App, designed to digitise sterility testing in …

FDA approves Amgen’s interchangeable biosimilar Bkemv

The US Food and Drug Administration (FDA) has approved Amgen's Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab) …

Vasomune wins FDA fast track designation for lung condition treatment

Vasomune Therapeutics has announced that its novel investigational medicine, AV-001, has received US Food and Drug Administration (FDA) fast track …